Product image of Kobey (Ezetimibe) supplied by GNH India

Kobey

Active Ingredient:
Ezetimibe
Origin:
EU

Kobey (Ezetimibe)

Ezetimibe, the active ingredient in Kobey, is a cholesterol absorption inhibitor presented as an oral dosage form for oral use. It reduces the absorption of dietary and biliary cholesterol and is used to manage elevated cholesterol levels in adults with primary hypercholesterolemia, heterozygous familial hypercholesterolemia, and other lipid disorders.

GNH India supplies Kobey as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

I.B.N. Savio S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kobey (ezetimibe) acts on cholesterol metabolism to lower lipid concentrations in the blood.

  • Hypercholesterolemia: lowers total and LDL‑cholesterol levels.
  • Heterozygous familial hypercholesterolemia: helps achieve target cholesterol reductions when used alone or with statins.
  • Primary hyperlipidemia: contributes to overall lipid profile improvement as part of a therapeutic regimen.

How It Works

  • Ezetimibe selectively inhibits the intestinal Niemann‑Pick C1‑Like 1 (NPC1L1) transporter, which is responsible for the uptake of dietary and biliary cholesterol. By blocking this transporter, ezetimibe reduces the amount of cholesterol delivered to the liver, leading to decreased hepatic cholesterol stores and up‑regulation of LDL receptors, thereby lowering circulating LDL‑cholesterol levels.

Side Effects

Ezetimibe is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhea: occasional loose stools.
  • Abdominal pain: discomfort in the stomach area.
  • Fatigue: feeling of tiredness.
  • Arthralgia: joint pain.
  • Upper respiratory tract infection: mild cold‑like symptoms.

Serious or Rare Side Effects

  • Myopathy: muscle pain or weakness, especially when combined with statins.
  • Elevated liver enzymes: possible hepatic injury.
  • Severe allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Pancreatitis: abdominal pain with nausea.
  • Cholestatic hepatitis: jaundice and liver dysfunction.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Liver function monitoring: assess baseline and periodic liver enzymes.
  • Pregnancy assessment: evaluate risks and benefits before use in pregnant patients.
  • Concomitant statin therapy: monitor for muscle-related symptoms.
  • Renal function evaluation: adjust use in severe renal impairment.
  • Patient counseling: advise on recognizing signs of myopathy or liver injury.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Ezetimibe may interact with other medicines; awareness of interaction severity is essential.

Major Interactions (Avoid)

  • Cyclosporine: increases ezetimibe plasma concentrations; avoid co‑administration.

Moderate Interactions (Monitor Closely)

  • Statins (e.g., simvastatin, atorvastatin): heightened risk of myopathy; monitor muscle symptoms.
  • Warfarin: possible alteration of INR; check coagulation status regularly.
  • Antacids (e.g., aluminum hydroxide): may reduce ezetimibe absorption; separate dosing times.
  • Bile acid sequestrants (e.g., cholestyramine): can lower ezetimibe effectiveness; stagger administration.

Frequently Asked Questions

Kobey contains ezetimibe, which is prescribed to lower elevated cholesterol levels in conditions such as hypercholesterolemia, heterozygous familial hypercholesterolemia, and primary hyperlipidemia. It works as part of a broader lipid‑lowering strategy, often together with diet, exercise, and other medications.

Ezetimibe blocks the NPC1L1 transporter in the small intestine, preventing the absorption of dietary and biliary cholesterol. This reduction in intestinal cholesterol uptake leads to lower circulating LDL‑cholesterol and supports overall lipid management.

The dosage of Kobey is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety of ezetimibe in pregnancy or while breastfeeding has not been fully established. Healthcare providers should weigh potential benefits against possible risks before prescribing Kobey to pregnant or nursing individuals.

To place an order, submit an enquiry on the Kobey product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Kobey (ezetimibe) differs from statins, which inhibit cholesterol synthesis in the liver. Ezetimibe targets intestinal absorption, making it useful as monotherapy or in combination with statins for patients needing additional LDL‑cholesterol reduction or who cannot tolerate higher statin doses.

Kobey should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Kobey is taken orally, usually once daily, with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water and do not crush or chew it unless specifically instructed.

Serious risks include muscle toxicity such as myopathy, especially when combined with statins, and liver injury indicated by elevated transaminases. Rarely, severe allergic reactions or pancreatitis may occur. Patients should report unexplained muscle pain, weakness, or jaundice promptly.

Kobey is contraindicated in individuals with known hypersensitivity to ezetimibe or any of its excipients. Caution is advised for patients with active liver disease, severe renal impairment, or those taking medications that may interact significantly, such as cyclosporine.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ezetimibe

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT